Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Zanzalintinib | 2367004-54-2 | 99.91% | 528.53 | 50 MG
Supplier: Medchemexpress LLC HY13869650MG
Zanzalintinib (XL092) is an orally active, ATP-competitive inhibitor of multiple receptor tyrosine kinases (RTKs) including MET, VEGFR2, AXL, and MER. It exhibits anti-tumor activity and has potential for research in kinase-dependent diseases and conditions.
- Orally active, ATP-competitive inhibitor
- Targets MET, VEGFR2, AXL, and MER
- Exhibits anti-tumor activity
- Potential for kinase-dependent diseases and conditions research
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?